- Home
- LQDT vs SNDX Comparison
LQDT vs SNDX Comparison
Compare LQDT & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDT
- SNDX
- Stock Information
- Founded
- LQDT 1999
- SNDX 2005
- Country
- LQDT United States
- SNDX United States
- Employees
- LQDT N/A
- SNDX N/A
- Industry
- LQDT Catalog/Specialty Distribution
- SNDX Biotechnology: Pharmaceutical Preparations
- Sector
- LQDT Consumer Discretionary
- SNDX Health Care
- Exchange
- LQDT Nasdaq
- SNDX Nasdaq
- Market Cap
- LQDT 975.1M
- SNDX 1.1B
- IPO Year
- LQDT 2006
- SNDX 2016
- Fundamental
- Price
- LQDT $34.56
- SNDX $13.08
- Analyst Decision
- LQDT Strong Buy
- SNDX Strong Buy
- Analyst Count
- LQDT 2
- SNDX 10
- Target Price
- LQDT $38.50
- SNDX $36.20
- AVG Volume (30 Days)
- LQDT 275.5K
- SNDX 2.6M
- Earning Date
- LQDT 02-06-2025
- SNDX 02-25-2025
- Dividend Yield
- LQDT N/A
- SNDX N/A
- EPS Growth
- LQDT N/A
- SNDX N/A
- EPS
- LQDT 0.63
- SNDX N/A
- Revenue
- LQDT $363,318,000.00
- SNDX $16,000,000.00
- Revenue This Year
- LQDT $31.09
- SNDX N/A
- Revenue Next Year
- LQDT N/A
- SNDX $14.15
- P/E Ratio
- LQDT $54.86
- SNDX N/A
- Revenue Growth
- LQDT 15.54
- SNDX N/A
- 52 Week Low
- LQDT $13.99
- SNDX $12.06
- 52 Week High
- LQDT $36.11
- SNDX $25.34
- Technical
- Relative Strength Index (RSI)
- LQDT 64.26
- SNDX 41.29
- Support Level
- LQDT $32.15
- SNDX $12.40
- Resistance Level
- LQDT $36.11
- SNDX $13.16
- Average True Range (ATR)
- LQDT 1.12
- SNDX 0.65
- MACD
- LQDT -0.04
- SNDX 0.10
- Stochastic Oscillator
- LQDT 69.49
- SNDX 39.38
About LQDT Liquidity Services Inc.
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.